Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions primarily emphasize the review's findings that blue-light therapy is not convincingly effective for depression, with phrases like 'no evidence,' 'efficacy remains unproven,' and detailed mentions of meta-analytical results. Users' tone is straightforward and clinical, reflecting a moderate level of interest and engagement but limited perceived impact on clinical practice.
Most discussions align with the article's conclusion that blue-light therapy lacks proven efficacy, supported by phrases like 'remains unproven' and 'no evidence.'
The conversations show a neutral level of curiosity, mainly summarizing findings without deep exploration or critique.
Some posts reference specific details from the review, such as the number of trials or the types of analyses, indicating moderate engagement.
The overall tone suggests limited impact, as the focus is on confirming the current lack of evidence rather than promoting a paradigm shift or innovative ideas.
Our group's newest paper, led by Dr. Andre Do of @UBC_Psychiatry, concludes that "the efficacy of blue-light therapy in the treatment of seasonal and non-seasonal MDD remains unproven". Read more at: https://t.co/CWdbVnainc @TheCJPsych @DrRaymondLam @LakshmiYatham
In the October issue - Blue-light therapy for depression? In a new systematic review and meta-analysis, Do et al. find: "The efficacy of blue-light therapy in the treatment of seasonal and non-seasonal MDD remains unproven." https://t.co/rMOaYp8PyU
RT @erin_michalak: Our group's newest paper, led by Dr. Andre Do of @UBC_Psychiatry, concludes that "the efficacy of blue-light therapy in…
RT @TheCJPsych: In the October issue - Blue-light therapy for depression? In a new systematic review and meta-analysis, Do et al. find: "T…
RT @TheCJPsych: In the October issue - Blue-light therapy for depression? In a new systematic review and meta-analysis, Do et al. find: "T…
RT @erin_michalak: Our group's newest paper, led by Dr. Andre Do of @UBC_Psychiatry, concludes that "the efficacy of blue-light therapy in…
Seasonal depression is common in fall and winter, characterized by low motivation and cravings for unhealthy food. This video explains the causes and discusses the effectiveness of light therapy, including blue-light…
This episode explores how the built environment affects our thoughts, feelings, and social connections, focusing on sensory perception, neuroarchitecture, and how thoughtful design supports mental health and community…
Review of 9 trials on 347 people shows #blue_light therapy's effectiveness for #depression is unclear, matching placebo outcomes. Suggests larger, longer studies for definitive answers. https://t.co/Lj3BkDPzda
RT @TheCJPsych: In the October issue - Blue-light therapy for depression? In a new systematic review and meta-analysis, Do et al. find: "T…
RT @TheCJPsych: In the October issue - Blue-light therapy for depression? In a new systematic review and meta-analysis, Do et al. find: "T…
RT @TheCJPsych: In the October issue - Blue-light therapy for depression? In a new systematic review and meta-analysis, Do et al. find: "T…
RT @TheCJPsych: In the October issue - Blue-light therapy for depression? In a new systematic review and meta-analysis, Do et al. find: "T…
In the October issue - Blue-light therapy for depression? In a new systematic review and meta-analysis, Do et al. find: "The efficacy of blue-light therapy in the treatment of seasonal and non-seasonal MDD remains unproven." https://t.co/rMOaYp8PyU
MA: The efficacy of blue-light therapy in the treatment of seasonal and non-seasonal MDD remains unproven. No evidence for the efficacy vs. inactive conditions (MD=2.43; −1.28 to 6.14) or active conditions (−0.11; −2.38 to 2.16) https://t.co/q2YIn4aqhY https://t.co/ldRz8zGCJ5
"there is no current evidence supporting the efficacy of blue-light therapy since our primary and sensitivity analyses for studies with inactive conditions were both negative. "https://t.co/wUmx0ANWhV
RT @erin_michalak: Our group's newest paper, led by Dr. Andre Do of @UBC_Psychiatry, concludes that "the efficacy of blue-light therapy in…
RT @erin_michalak: Our group's newest paper, led by Dr. Andre Do of @UBC_Psychiatry, concludes that "the efficacy of blue-light therapy in…
RT @erin_michalak: Our group's newest paper, led by Dr. Andre Do of @UBC_Psychiatry, concludes that "the efficacy of blue-light therapy in…
Our group's newest paper, led by Dr. Andre Do of @UBC_Psychiatry, concludes that "the efficacy of blue-light therapy in the treatment of seasonal and non-seasonal MDD remains unproven". Read more at: https://t.co/CWdbVnainc @TheCJPsych @DrRaymondLam @LakshmiYatham
MA: no evidence for the efficacy of blue-light conditions vs. inactive conditions in the treatment of seasonal and non-seasonal MDD (MD= 2.43; −1.28 to 6.14). There were no significant differences in response and remission rates either https://t.co/q2YIn4aqhY
The efficacy of blue-light therapy in the treatment of seasonal and non-seasonal MDD remains unproven. https://t.co/wUmx0AwkTl